EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Operationalizing a Decision‐Making for Adverse Event Reporting Toolkit ( DART ) for Aging and Serious Illness Research

Sara Lubetsky iD, Christopher Woodrell, Gabrielle Schiller, Brynn Bowman iD, Rachael Heitner, R Sean Morrison, Albert L Siu, Dalane Kitzman, Abigail Baim-Lance

Journal of the American Geriatrics Society · 2026-06 · 74 (6) · 1692-1697

DOI: 10.1111/jgs.70373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 09.04.2026. Verfasst von Sara Lubetsky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Decision Making, Adverse Drug Reaction Reporting Systems, Aging, Clinical Trials as Topic. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Monitoring adverse events (AEs) assures patient safety in clinical trials. Studies involving seriously ill and older adults can have a high volume of AEs related to underlying courses of illness rather than study procedures. Trials not regulated by the Food and Drug Administration (FDA) can incur excessive reporting burden beyond that required for compliance or patient safety assurance. In 2021, a working group proposed an alternative approach to AE evaluation, emphasizing routine, aggregate reporting, and reserving expedited reporting of individual AEs for serious events at least possibly related to study procedures and not aligned with goals of care. Another outcome was a call to operationalize the approach for eventual implementation.

Methods

A panel comprising 31 leaders from government agencies, professional organizations, aging and serious illness research communities, research administration, and medical ethics met five times in 2024–2025. The panel advised on deliverables, assessed concept acceptability, and reviewed tools; a multidisciplinary project team generated content and incorporated feedback. Research compliance experts reviewed the final decision algorithm.

Results

The resulting Decision‐Making for Adverse Event Reporting Toolkit Tailored to Social, Behavioral and Health Services Studies involving Seriously Ill and Older Adult Populations (DART) is a novel research tool to support researchers in AE evaluation. The decision algorithm assesses: (1) relatedness, (2) goals of care alignment, (3) seriousness, and (4) greater risk of harm. The toolkit includes a case series, frequently asked questions, and reporting form. Feedback emphasized DART applies to any study population and intervention type not regulated by the FDA.

Conclusions

DART provides a novel solution to AE reporting challenges faced by aging and serious illness researchers. While its design centers on seriously ill older adults, DART can likely be applied to research in any population and intervention type not regulated by the FDA. Future pilot testing will inform implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision MakingAdverse Drug Reaction Reporting SystemsAgingClinical Trials as TopicBiomedical ResearchHumansUnited StatesUnited States Food and Drug AdministrationAgedPatient SafetyDrug-Related Side Effects and Adverse Reactions

Stichwörter der Autor:innen

adverse event reportingbehavioral trialsresearch administrationresearch compliance

Autor:innen und Institutionen

  • Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Geriatric Research Education and Clinical Center, James J Peters VA Medical Center, Bronx, New York, USA.
  • Center to Advance Palliative Care, Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Internal Medicine: Sections on Cardiovascular Medicine and Geriatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

ORCID-Profile: Sara Lubetsky, Brynn Bowman

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Lubetsky, S., Woodrell, C., Schiller, G., Bowman, B., Heitner, R., Morrison, R. S., Siu, A. L., Kitzman, D., & Baim-Lance, A. (2026). Operationalizing a Decision‐Making for Adverse Event Reporting Toolkit ( DART ) for Aging and Serious Illness Research. Journal of the American Geriatrics Society, 74(6), 1692-1697. https://doi.org/10.1111/jgs.70373

Vancouver

Lubetsky S, Woodrell C, Schiller G, Bowman B, Heitner R, Morrison RS, et al. Operationalizing a Decision‐Making for Adverse Event Reporting Toolkit ( DART ) for Aging and Serious Illness Research. Journal of the American Geriatrics Society. 2026;74(6):1692-1697. doi:10.1111/jgs.70373

BibTeX
@article{Lubetsky2026,
  author = {Lubetsky, Sara and Woodrell, Christopher and Schiller, Gabrielle and Bowman, Brynn and Heitner, Rachael and Morrison, R Sean and Siu, Albert L and Kitzman, Dalane and Baim-Lance, Abigail},
  title = {Operationalizing a Decision‐Making for Adverse Event Reporting Toolkit ( DART ) for Aging and Serious Illness Research},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  volume = {74},
  number = {6},
  pages = {1692--1697},
  doi = {10.1111/jgs.70373}
}
Kostenlos starten →